Search This Blog

Wednesday, August 7, 2019

Eloxx Pharmaceuticals EPS misses by $0.05

Eloxx Pharmaceuticals (NASDAQ:ELOX): Q2 GAAP EPS of -$0.40 misses by $0.05.
Cash and equivalents of $49.33M
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)